Initial fixed low-versus moderate-dose hydroxyurea assignment in the long-term follow-up of the SPRINT cohort.

Authors

Shamsu Muhammad Iguda, Shehu U Abdullahi, Ibrahim Musa Idris, Abdulkadir Halifa Yusuf, Surayya Murtala Sunusi, Khadijah A Bulama, Hauwau Aminu Inuwa, Mark J Rodeghier, Michael R DeBaun

Published in

Blood. Oct 26, 2026. Epub Oct 26, 2026.

Abstract

In this pragmatic long-term follow-up of the SPRINT randomized trial cohort, rates of recurrent stroke and all-cause mortality did not differ significantly by an initial fixed low- versus moderate-dose of hydroxyurea over 4.9 years, with events clustering in the first year.

PMID:
42932254
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.